{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:13:49Z","timestamp":1772460829652,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Long QT syndrome (LQTS) is a cardiac channelopathy characterized by impaired myocardial repolarization that predisposes to life-threatening arrhythmias. This study aimed to elucidate the genetic basis of LQTS in an affected Iranian family using whole exome sequencing (WES).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A 37-year-old woman with a personal and family history of sudden cardiac arrest and LQTS was referred for genetic study after losing her teenage daughter due to sudden cardiac death (SCD). WES was performed and variants were filtered and prioritized based on quality, allele frequency, pathogenicity predictions, and conservation scores. Sanger sequencing confirmed segregation in the family.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>WES identified a novel heterozygous frameshift variant (NM_000238.4:c.3257_3258insG; pGly1087Trpfs*32) in the <jats:italic>KCNH2<\/jats:italic> encoding the \u03b1-subunit of the rapid delayed rectifier potassium channel responsible for cardiac repolarization. This variant, predicted to cause a truncated protein, is located in the C-terminal region of the channel and was classified as likely pathogenic based on ACMG guidelines. The variant was absent in population databases and unaffected family members.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study reports a novel <jats:italic>KCNH2<\/jats:italic> frameshift variant in an Iranian family with LQTS, expanding the spectrum of disease-causing variants in this gene. Our findings highlight the importance of the C-terminal region in KCNH2 for proper channel function and the utility of WES in identifying rare variants in genetically heterogeneous disorders like LQTS. Functional characterization of this variant is warranted to fully elucidate its pathogenic mechanisms and inform personalized management strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-024-01900-z","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T15:02:18Z","timestamp":1715094138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection of a novel pathogenic variant in KCNH2 associated with long QT syndrome 2 using whole exome sequencing"],"prefix":"10.1186","volume":"17","author":[{"given":"Erfan","family":"Kohansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloofar","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Farjam","family":"Fazelifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Kalayinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"1900_CR1","doi-asserted-by":"publisher","first-page":"212178","DOI":"10.1100\/2012\/212178","volume":"2012","author":"EM Kallergis","year":"2012","unstructured":"Kallergis EM, Goudis CA, Simantirakis EN, Kochiadakis GE, Vardas PE. Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. ScientificWorldJournal. 2012;2012:212178.","journal-title":"ScientificWorldJournal"},{"issue":"8","key":"1900_CR2","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1017\/S1047951120001808","volume":"30","author":"D Giray","year":"2020","unstructured":"Giray D, Donmez YN, Epcacan S, Goktas E. A rare coincidence: the long QT syndrome and cardio-facio-cutaneous syndrome. Cardiol Young. 2020;30(8):1209\u201311.","journal-title":"Cardiol Young"},{"issue":"18","key":"1900_CR3","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","volume":"120","author":"PJ Schwartz","year":"2009","unstructured":"Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120(18):1761\u20137.","journal-title":"Circulation"},{"issue":"14","key":"1900_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1056\/NEJM199810013391404","volume":"339","author":"W Zareba","year":"1998","unstructured":"Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, et al. Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339(14):960\u20135.","journal-title":"N Engl J Med"},{"key":"1900_CR5","unstructured":"Adkison LR. Elsevier\u2019s Integrated Review Genetics E-Book: with STUDENT CONSULT Online Access. 2011."},{"issue":"17","key":"1900_CR6","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1113\/jphysiol.2013.254920","volume":"591","author":"AS Amin","year":"2013","unstructured":"Amin AS, Pinto YM, Wilde AA. Long QT syndrome: beyond the causal mutation. J Physiol. 2013;591(17):4125\u201339.","journal-title":"J Physiol"},{"issue":"11","key":"1900_CR7","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.cjco.2021.06.005","volume":"3","author":"WC Kim","year":"2021","unstructured":"Kim WC, Lemire E, Nosib S, Nosib SA, Novel Frameshift, Mutation. KCNH2 [p.Asp896ArgfsX79], leading to malignant ventricular arrhythmia, identified after treatment of gastrointestinal bleeding. CJC Open. 2021;3(11):1383\u20137.","journal-title":"CJC Open"},{"issue":"10","key":"1900_CR8","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013\u201322.","journal-title":"N Engl J Med"},{"issue":"Pt 1","key":"1900_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1469-7793.2001.t01-3-00001.x","volume":"534","author":"E Aydar","year":"2001","unstructured":"Aydar E, Palmer C. Functional characterization of the C-terminus of the human ether-\u00e0-go-go-related gene K(+) channel (HERG). J Physiol. 2001;534(Pt 1):1\u201314.","journal-title":"J Physiol"},{"issue":"8","key":"1900_CR10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/biom10081144","volume":"10","author":"M Ono","year":"2020","unstructured":"Ono M, Burgess DE, Schroder EA, Elayi CS, Anderson CL, January CT, et al. Long QT syndrome type 2: emerging strategies for correcting class 2 KCNH2 (hERG) mutations and identifying new patients. Biomolecules. 2020;10(8):1144.","journal-title":"Biomolecules"},{"issue":"5","key":"1900_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"key":"1900_CR12","unstructured":"Hille B. Potassium channels and chloride channels. In Ionic Channels of Excitable Membrane. Edited by Hill B. 1992:130-3."},{"issue":"3","key":"1900_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cell.2017.03.048","volume":"169","author":"W Wang","year":"2017","unstructured":"Wang W, MacKinnon R. Cryo-EM structure of the Open Human Ether-a-go-go-related K(+) Channel hERG. Cell. 2017;169(3):422\u201330. e10.","journal-title":"Cell"},{"issue":"9","key":"1900_CR14","doi-asserted-by":"publisher","first-page":"6331","DOI":"10.1111\/jcmm.14521","volume":"23","author":"R De Zio","year":"2019","unstructured":"De Zio R, Gerbino A, Forleo C, Pepe M, Milano S, Favale S, et al. Functional study of a KCNH2 mutant: novel insights on the pathogenesis of the LQT2 syndrome. J Cell Mol Med. 2019;23(9):6331\u201342.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1900_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/01.RES.84.3.290","volume":"84","author":"N Neyroud","year":"1999","unstructured":"Neyroud N, Richard P, Vignier N, Donger C, Denjoy I, Demay L, et al. Genomic organization of the KCNQ1 K\u2009+\u2009channel gene and identification of C-terminal mutations in the long-QT syndrome. Circ Res. 1999;84(3):290\u20137.","journal-title":"Circ Res"},{"issue":"15","key":"1900_CR16","doi-asserted-by":"publisher","first-page":"10113","DOI":"10.1074\/jbc.274.15.10113","volume":"274","author":"J Chen","year":"1999","unstructured":"Chen J, Zou A, Splawski I, Keating MT, Sanguinetti MC. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J Biol Chem. 1999;274(15):10113\u20138.","journal-title":"J Biol Chem"},{"issue":"3","key":"1900_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/emboj\/cdg035","volume":"22","author":"M Jenke","year":"2003","unstructured":"Jenke M, Sanchez A, Monje F, Stuhmer W, Weseloh RM, Pardo LA. C-terminal domains implicated in the functional surface expression of potassium channels. EMBO J. 2003;22(3):395\u2013403.","journal-title":"EMBO J"},{"issue":"42","key":"1900_CR18","doi-asserted-by":"publisher","first-page":"27231","DOI":"10.1074\/jbc.273.42.27231","volume":"273","author":"S Kupershmidt","year":"1998","unstructured":"Kupershmidt S, Snyders DJ, Raes A, Roden DM. A K\u2009+\u2009channel splice variant common in human heart lacks a C-terminal domain required for expression of rapidly activating delayed rectifier current. J Biol Chem. 1998;273(42):27231\u20135.","journal-title":"J Biol Chem"},{"issue":"30","key":"1900_CR19","doi-asserted-by":"publisher","first-page":"27442","DOI":"10.1074\/jbc.M112375200","volume":"277","author":"S Kupershmidt","year":"2002","unstructured":"Kupershmidt S, Yang T, Chanthaphaychith S, Wang Z, Towbin JA, Roden DM. Defective human ether-a-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus. J Biol Chem. 2002;277(30):27442\u20138.","journal-title":"J Biol Chem"},{"issue":"2","key":"1900_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0008-6363(99)00195-9","volume":"44","author":"T Nakajima","year":"1999","unstructured":"Nakajima T, Furukawa T, Hirano Y, Tanaka T, Sakurada H, Takahashi T, et al. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2. Cardiovasc Res. 1999;44(2):283\u201393.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1900_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.yjmcc.2004.09.010","volume":"37","author":"T Sasano","year":"2004","unstructured":"Sasano T, Ueda K, Orikabe M, Hirano Y, Kawano S, Yasunami M, et al. Novel C-terminus frameshift mutation, 1122\u00a0fs\/147, of HERG in LQT2: additional amino acids generated by frameshift cause accelerated inactivation. J Mol Cell Cardiol. 2004;37(6):1205\u201311.","journal-title":"J Mol Cell Cardiol"},{"issue":"33","key":"1900_CR22","doi-asserted-by":"publisher","first-page":"21061","DOI":"10.1074\/jbc.273.33.21061","volume":"273","author":"Z Zhou","year":"1998","unstructured":"Zhou Z, Gong Q, Epstein ML, January CT. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem. 1998;273(33):21061\u20136.","journal-title":"J Biol Chem"},{"issue":"3","key":"1900_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cardiores.2005.05.017","volume":"67","author":"AD Paulussen","year":"2005","unstructured":"Paulussen AD, Raes A, Jongbloed RJ, Gilissen RA, Wilde AA, Snyders DJ, et al. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency. Cardiovascular Res. 2005;67(3):467\u201375.","journal-title":"Cardiovascular Res"},{"issue":"5","key":"1900_CR24","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.hrthm.2016.01.012","volume":"13","author":"A Puckerin","year":"2016","unstructured":"Puckerin A, Aromolaran KA, Chang DD, Zukin RS, Colecraft HM, Boutjdir M, et al. hERG 1a LQT2 C-terminus truncation mutants display hERG 1b-dependent dominant negative mechanisms. Heart Rhythm. 2016;13(5):1121\u201330.","journal-title":"Heart Rhythm"},{"issue":"19","key":"1900_CR25","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1093\/hmg\/ddl230","volume":"15","author":"C-u Choe","year":"2006","unstructured":"Choe C-u, Schulze-Bahr E, Neu A, Xu J, Zhu ZI, Sauter K, et al. C-terminal HERG (LQT2) mutations disrupt I kr channel regulation through 14-3-3\u03f5. Hum Mol Genet. 2006;15(19):2888\u2013902.","journal-title":"Hum Mol Genet"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01900-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-024-01900-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01900-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T15:08:43Z","timestamp":1715094523000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-024-01900-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1186\/s12920-024-01900-z","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"20 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complies with the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committees of Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran (IR.RHC.REC.1402.003). Informed consent must have been obtained from a participant and their parents or legal guardians for minors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"During the preparation of this work the authors used Claude 2.1 in order to ensure English language fluency and native quality writing. Claude was consulted regarding grammar, word choice, sentence structure, and overall clarity of expression. After using this service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"All the participants\/patient and parents of the minor participants gave written informed consent for their personal or clinical details along with any identifying images to be published in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}